Diabetes drug for adults may help obese youths lose weight

02/4/2013 | Reuters

Severely obese youths who received exenatide injections twice a day for three months lost about 7 pounds more than the placebo group, according to a study in JAMA Pediatrics. Initially approved by the FDA for adults with type 2 diabetes, exenatide showed potential "in terms of weight reduction and cardiovascular risk control," lead author Aaron Kelly said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX